GlaxoSmithKline bags an FDA OK for its asthma drug with eyes on a respiratory turnaround

Damian Garde

won FDA approval for an antibody designed to treat severe , leading a pack of drugmakers at work on similar therapies as it seeks to bolster its business.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS